Number of Patients With Evaluable Data
Parameter . | No. of . | Parameter . | No. of . |
---|---|---|---|
. | Patients . | . | Patients . |
PB | |||
WBC | 110 | Spleen size in cm | 106 |
Differential count | 100 | Liver size in cm | 105 |
Platelets* | 106 | Karyotype | 98 |
Hb* | 107 | LDH† | 82 |
MCV | 79 | Ig G† | 81 |
Reticulocytes | 60 | IgM† | 79 |
Hb F | 91 | IgA† | 79 |
BM | |||
Cell content | 100 | Antinuclear antibodies† | 29 |
Megakaryocytes | 89 | Direct Coombs test | 22 |
Differential count | 92 | Lysozyme† | 29 |
Parameter . | No. of . | Parameter . | No. of . |
---|---|---|---|
. | Patients . | . | Patients . |
PB | |||
WBC | 110 | Spleen size in cm | 106 |
Differential count | 100 | Liver size in cm | 105 |
Platelets* | 106 | Karyotype | 98 |
Hb* | 107 | LDH† | 82 |
MCV | 79 | Ig G† | 81 |
Reticulocytes | 60 | IgM† | 79 |
Hb F | 91 | IgA† | 79 |
BM | |||
Cell content | 100 | Antinuclear antibodies† | 29 |
Megakaryocytes | 89 | Direct Coombs test | 22 |
Differential count | 92 | Lysozyme† | 29 |